Segregated mathematical model for growth of anchorage-dependent MDCK cells in microcarrier culture

Biotechnology Progress

Volumn 24, Issue 1, 2008, Pages 110-119

  Mönier, Lars ^a   Bock, Andreas ^b   Reichl, Udo ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; MATHEMATICAL MODELS; METABOLITES; OPTIMIZATION; VACCINES;

CELL ATTACHMENT; GROWTH INHIBITORS; MICROCARRIER CULTURE; MICROCARRIER SYSTEMS;

CELL GROWTH;

ALGORITHM; ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; CELL LINE; CELL PROLIFERATION; COMPUTER SIMULATION; CONFERENCE PAPER; CULTURE TECHNIQUE; DOG;

ALGORITHMS; ANIMALS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; COMPUTER SIMULATION; DOGS; MODELS, BIOLOGICAL;

MAMMALIA;

EID: 38949153800     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0701923     Document Type: Conference Paper

References (57)

1. Batt, B. C.; Kompala, D. S. A structured kinetic modeling framework for the dynamics of hybridoma growth and monoclonal antibody production in continuous suspension cultures. Biotechnol. Bioeng. 1988, 34, 515-531.
2. Biener, R.; Noé, W.; Haas, J.; Schuller, D.; Schorn, P.; Gilles, E. D. Metabolisch strukturierte Modellierung und modellgestützte Prozessführung tierischer Zellkulturen. Automatisierungstechnik 1998, 46 (8), 386-394.
3. Birch, J.; Onakunle, Y. Biopharmaceutical proteins: opportunities and challenges. Methods Mol. Biol. 2005, 308, 1-16.
4. Blüml, G. Microcarrier cell culture technology. In Animal Cell Biotechnology: Methods and Protocols; Pörtner, R., Ed.; Springer, Humana Press: Berlin, 2007; pp 149-178.
5. Bock, A.; Reichl, U. In Closed Loop Control of Perfusion Systems in High-Density Cell Culture; Proceedings of the 19th ESACT Meeting, Harrogate, UK, June, 2005, 2007; Smith, R., Ed.; Springer: Harrogate, U.K., 2007; pp 549-551.
6. TC: A safe Madin Darby canine kidney (MDCK) cell culture-based influenza vaccine. In Inactivated Influenza Vaccines Prepared in Cell Culture; Brown, F., Robertson, J. S., Schild, G., Wood, J. M. Eds.; Karger: Basel, 1999; Vol. 98, pp 93-100.
7. Chang, L.; Crichton, R.; Nandapalan, P. Cell culture influenza vaccine: an Australian perspective. Dev. Biol. Stand. 1998, 98, 177-181.
8. Cox, N.; Hannoun, C.; Hay, A.; Kaverin, N. V.; Kilbourne, E. D.; Webster, R.; Levandowski, R. A.; Schild, G.; Wood, J.; Ghendon, Y.; Grachev, V.; Griffiths, E.; Martinez, L. J. Cell culture as a substrate for the production of influenza vaccines-memorandum from a WHO meeting. Bull. World Health Org. 1995, 73 (4), 431-435.
9. Cruz, H. J.; Moreira, J. L.; Carrondo, M. J. Metabolic shifts by nutrient manipulation in continuous cultures of BHK cells. Biotechnol. Bioeng. 1999, 66 (2), 104-113.
10. Dhir, S.; Morrow, K. J.; Rhinehart, R. R.; Wiesner, T. Dynamic optimization of hybridoma growth in a fed-batch bioreactor. Biotechnol. Bioeng. 2000, 67 (2), 197-205.
11. DiMasi, D.; Swartz, R. An energetically structured model of mammalian cell metabolism. 1. Model development and application to steady-state hybridoma cell growth in continuous culture. Biotechnol. Prog. 1995, 11 (6), 664-676.
12. Doyle, A.; Griffiths, J. B. Hemacytometer cell counts and viability studies. In Cell and Tissue Culture for Medical Research; Doyle, A., Griffiths, J. B., Eds.; John Wiley and Sons, Ltd.: London, 2000.
13. Doyle, A.; Griffiths, J. B. Modeling. In Cell and Tissue Culture: Laboratory Procedures in Biotechnology; Doyle, A., Griffith, J. B., Eds.; Wiley: New York, 1998; pp 160-178.
14. Forestell, S.; Milne, B.; Kalogeratis, N.; Behie, L. A cellular automaton model for the growth of anchorage-dependent mammalian cells used in vaccine production. Chem. Eng. Sci. 1992, 47 (9-11), 2381-2386.
15. Frame, K. K.; Hu, W.-S. A model for density-dependent growth of anchorage-dependent mammalian cells. Biotechnol. Bioeng. 1988, 32, 1061-1066.
16. Frisch, S. M.; Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124 (4), 619-626.
17. GE Healthcare; Microcarrier Cell Culture: Principles and Methods; Handbook 18-1140-62. The handbook is available for download under the following link (17. Dec. 2007): http://www.rcxg.mdlc.com/aptrix/upp01077.nsf/Content/ Products?OpenDocument&parentid=666921&moduleid=166475.
18. Gebb, C.; Lundgren, B.; Clark, J.; Lindskog, U. Harvesting and subculturing cells growing on denatured-collagen coated microcarriers (Cytodex 3). Dev. Biol. Stand. 1983, 55, 57-65.
19. Genzel, Y.; Behrendt, I.; König, S.; Sann, H.; Reichl, U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 2004, 22, 2202-2208.
20. Genzel, Y.; Fischer, M.; Reichl, U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 2006, 24 (16), 3261-3272.
21. Genzel, Y.; Reichl, U. Vaccine production-state of the art and future needs in upstream processing. In Animal Cell Biotechnology-Methods and Protocols, 2 ed.; Pörtner, R., Ed.; Humana Press: Totowa, NJ 2007; pp 457-473.
22. Ghendon, Y. Z.; Markushin, S. G.; Akopova, II; Koptiaeva, I. B.; Nechaeva, E. A.; Mazurkova, L. A.; Radaeva, I. F.; Kolokoltseva, T. D. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 2005, 23 (38), 4678-4684.
23. Glacken, M. W.; Adema, E.; Sinskey, A. J. Mathematical description of hybridoma culture kinetics. 1. Initial metabolic rates. Biotechnol. Bioeng. 1988, 32, 491-506.
24. Glacken, M. W.; Fleischaker, R. J.; Sinskey, A. J. Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol. Bioeng. 1986, 28, 1376-1389.
25. Gröhn, P.; Klöck, G.; Zimmermann, U. Collagen-coated Ba(2+)-alginate microcarriers for the culture of anchorage-dependent mammalian cells. Biotechniques 1997, 22 (5), 970-975.
26. Häggström, L. Cell Metabolism, animal. In The Encyclopedia of Cell Technology; Spier, R. E., Ed.; Wiley-Interscience: New York, 2000; Vol. 1, pp 392-411.
27. Harigae, M.; Matsumura, M.; Kataoka, H. Kinetic study on HBs-MAb production in continuous cultivation. J. Biotechnol. 1994, 34 (3), 227-235.
28. Hassel, T.; Gleave, S.; Butler, M. Growth inhibition in animal cell culture. The effect of lactate and ammonia. Appl. Biochem. Biotechnol. 1991, 30 (1), 29-41.
29. Hawboldt, K. A.; Kalogerakis, N.; Behie, L. A. A cellular automaton model for microcarrier cultures. Biotechnol. Bioeng. 1994, 43, 90-100.
30. Hu, W.-S.; Giard, D. J.; Wang, D. I. Serial propagation of mammalian cells on microcarriers. Biotechnol. Bioeng. 1985a, 27, 1466-1476.
31. Hu, W.-S.; Meier, J.; Wang, D. A mechanistic analysis of the inoculum requirement for the cultivation of mammalian cells on microcarriers. Biotechnol. Bioeng. 1985b, 27, 585-595.
32. Keller, S. H.; Nigam, S. K. Biochemical processing of E-cadherin under cellular stress. Biochem. Biophys. Res. Commun. 2003, 307, 215-223.
33. Kistner, O.; Barrett, P. N.; Mundt, W.; Reiter, M.; Schober-Bendixen, S.; Eder, G.; Dorner, F. A novel mammalian cell (Vero) derived influenza virus vaccine: Development, characterization and industrial scale production. Wien. Klin. Wochenschr. 1999, 111 (5), 207-214.
34. Lim, J.; Davies, G. A stochastic model to simulate the growth of anchorage dependent cells on flat surfaces. Biotechnol. Bioeng. 1990, 36, 547-562.
35. Lindner, E.; Arvidsson, A.; Wergeland, I.; Billig, D. Subpassaging cells on microcarriers: the importance for scaling up to production. Dev. Biol. Stand. 1987, 66, 299-305.
36. M'Kendrick, A. G.; Pai, M. D. The rate of multiplication of microorganisms. Proc. R. Soc. Edinburgh 1911, 31, 649-655.
37. Merten, O.; Manuguerra, J.; Hannoun, C.; van der Werf, S. Production of influenza virus in serum-free mammalian cell cultures. Dev. Biol. Stand. 1999, 98, 23-37.
38. Miller, W. M.; Blanch, H. W.; Wilke, C. R. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH. Biotechnol. Bioeng. 1988, 32 (8), 947-965.
39. Möhler, L. Segregierte mathematische Modelle zum Wachstum adhärenter tierischer Zellen (MDCK) und zur Influenza Virus Replikation. Shaker: Aachen 2006; Vol. 15, p 142.
40. Möhler, L.; Flockerzi, D.; Sann, H.; Reichl, U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechol. Bioeng. 2005, 90 (1), 46-58.
41. Nielsen, U. K. Virus production from cell culture, kinetics. In Encyclopedia of Cell Technology; Spier, R. E., Ed.; John Wiley and Sons: New York, 2000; Vol. 2, pp 1217-1230.
42. Opitz, L.; Salaklang, J.; Buttner, H.; Reichl, U.; Wolff, M. W. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine 2007, 25 (5), 939-947.
43. Pau, M.; Ophost, C.; Koldijk, M.; Schouten, G.; Mehtali, M.; Uytdehaag, F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19 (17-19 Special Issue SI), 2716-2721.
44. Pörtner, R.; Schäfer, T. Modelling hybridoma cell growth and metabolism a comparison of selected models and data. J. Biotechnol. 1996, 48, 119-135.
45. Provost, A.; Bastin, G. Dynamic metabolic modelling under the balanced growth condition. J. Process Control 2004, 14, 717-728.
46. Ruaan, R.-C.; Tsai, G.-J.; Tsao, G. Monitoring and modeling density-dependent growth of anchorage-dependent cells. Biotechnol. Bioeng. 1993, 41, 380-389.
47. Schmid, G.; Blanch, H. W. Extra- and intracellular metabolite concentrations for murine hybridoma cells. Appl. Microbiol. Biotechnol. 1992,36, 621-625.
48. Tree, J. A.; Richardson, C.; Fooks, A. R.; Clegg, J. C.; Looby, D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 2001, 19, 3444-3450.
49. Voeten, J. T.; Brands, R.; Palache, A. M.; van Scharrenburg, G. J.; Rimmelzwaan, G. F.; Osterhaus, A. D.; Claas, E. C. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999, 17 (15-16), 1942-1950.
50. Vriezen, N.; van Dijken, J.; Häggström, L. Mammalian cell culture. In Basic Biotechnology, 2nd ed.; Ratledge, C., Kristiansen, B., Eds.; Cambridge University Press: Cambridge 2001; pp 449-470.
51. Werner, R.; Noe, W. Mammalian cell cultures. Part I: Characterization, morphology and metabolism. Arzneimittelforschung 1993, 43 (10), 1134-1139.
52. Wlaschin, K. F.; Hu, W. S. Fedbatch culture and dynamic nutrient feeding. Cell Cult. Eng. 2006, 101, 43-74.
53. Wu, S.; Liu, C.; Lian, W. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 2004, 22 (29-30), 3858-3864.
54. Yokomizo, A.; Antoniazzi, M.; Galdino, P.; Azambuja, N. J.; Jorge, S.; Pereira, C. Rabies virus production in high Vero cell density cultures on macroporous microcarriers. Biotechnol. Bioeng. 2004, 85 (5), 506-514.
55. Zielke, H.; Zielke, C.; Ozand, P. Glutamine: a major energy source for cultured mammalian cells. Fed. Proc. 1984, 43 (1), 121-125.
56. Zygourakis, K.; Bizios, R.; Markenscoff, P. Proliferation of anchorage-dependent contact-inhibited cells. I. Development of theoretical models based on cellular automata. Biotechnol. Bioeng. 1991a, 38, 459-470.
57. Zygourakis, K.; Markenscoff, P.; Bizios, R. Proliferation of anchorage-dependent contact-inhibited cells. II. Experimental results and validation of the theoretical models. Biotechnol. Bioeng. 1991b, 38, 471-480.